THE ELITE UNIVERSAL TEST BANK:
RHODE ISLAND PHARMACY
JURISPRUDENCE & GLOBAL STANDARDS
PART 0: THE NAVIGATOR
● Tier 1 (Questions 1–28) - Foundational Syntax & Application: Regulatory timelines,
the Uniform MPJE (UMPJE) transition, controlled substance hard-decks, and baseline
licensing metrics.
● Tier 2 (Questions 29–58) - Complex Application & Simulation: Pharmacist-prescribed
contraceptives, 100-day emergency continuation protocols, PDMP surveillance triggers,
and dynamic staffing regulations.
● Tier 3 (Questions 59–88) - Grandmaster Synthesis: Collaborative Practice Agreements
(CPA), multi-jurisdictional telemedicine friction, test-and-treat execution, and systemic
failure resolution.
PART I: THE PRIMER
Mastering this test bank forges practitioners into elite, liability-proof scholars capable of
dominating the 2026 Rhode Island jurisprudence landscape and translating regulatory theory
into unassailable clinical competence. By fusing hyper-specific state statutes with universal
healthcare governance, this material structurally shields the professional from catastrophic civil,
regulatory, and criminal exposure while optimizing patient outcomes.
The "Critical Axioms" Cheat Sheet:
● The 2026 UMPJE Mandate: The state-specific Rhode Island MPJE was permanently
abolished. As of April 1, 2026, licensure by examination or reciprocity unequivocally
requires passage of the Uniform Multistate Pharmacy Jurisprudence Examination
(UMPJE).
● The 100-Day Safety Net: Under R.I. Gen. Laws § 5-19.1-37, pharmacists possess the
unilateral authority to dispense a 100-day continuation refill for essential, non-controlled
maintenance medications if a prescriber is unreachable or the patient is orphaned.
● The Non-Opioid 90/90 Rule: Schedule II prescriptions expire exactly 90 days from
issuance. Following a radical 2025 legislative update, prescribers may now authorize, and
pharmacists may dispense, up to a 90-day supply of non-opioid, non-narcotic C-IIs (e.g.,
ADHD stimulants) in a single transaction.
● Acute Opioid Hard Deck: Initial acute pain opioid prescriptions are mathematically
restricted. They must not exceed 20 individual doses, nor may they surpass a maximum
threshold of 30 Morphine Milligram Equivalents (MME) per day.
Rhode Island 2026/2027 Core Regulatory Metrics
Metric Statutory Standard Citation
Pharmacist CE Requirement 15 Hours Annually (5 Live, 1
,Metric Statutory Standard Citation
Immunization)
Record Retention 2 Years from Date of
(Prescriptions) Dispensing
Record Retention (Medicaid 10 Years
Logs)
Pharmacist-to-Technician No statutory maximum;
Ratio determined by PIC
Dispensing Error Reporting Within 30 days to a Patient
Safety Organization
PART II: THE ELITE TEST BANK
Tier 1 - Foundational Syntax & Application
Q1: An out-of-state pharmacist applies for reciprocity in Rhode Island in May 2026. Based on
the rules of the Rhode Island Board of Pharmacy, which examination MUST they successfully
complete? A) The Rhode Island specific Multistate Pharmacy Jurisprudence Examination
(MPJE) B) The Multistate Pharmacy Jurisprudence Examination (MPJE) from their home
jurisdiction C) The Uniform Multistate Pharmacy Jurisprudence Examination (UMPJE) D) A
50-question oral jurisprudence board review
● The Answer: C (The Uniform Multistate Pharmacy Jurisprudence Examination (UMPJE))
● Distractor Analysis:
○ A is incorrect: The RI MPJE was permanently retired on April 1, 2026.
○ B is incorrect: Home-state MPJEs do not satisfy the 2026 RI reciprocal requirement.
○ D is incorrect: Oral reviews are legacy mechanics not utilized for standard modern
reciprocity.
The Mentor's Analysis: Regulatory frameworks standardize to remove friction. When facing
jurisdictional entry post-April 2026, the immediate priority is recognizing the UMPJE mandate.
By utilizing the Uniform MPJE compliance pathway, you bypass the novice error of studying
defunct state-specific test structures. Geography yields to uniformity; the UMPJE is the
absolute standard for 2026 RI licensure.
Q2: A licensed Rhode Island pharmacist is auditing their continuing education (CE) credits. To
maintain an active license, how many total hours of CE are REQUIRED per calendar year? A)
10 hours B) 15 hours C) 20 hours D) 30 hours
● The Answer: B (15 hours)
● Distractor Analysis:
○ A is incorrect: This falls below the statutory minimum.
○ C is incorrect: This is a common biennial requirement in other states, but RI tracks
annually.
○ D is incorrect: This represents the requirement for states with biennial 30-hour
cycles.
The Mentor's Analysis: Competency maintenance is a strict annual liability. When renewing
credentials, the immediate priority is fulfilling the baseline 15-hour state mandate. By utilizing
the annual cycle, you bypass audit failures. Rhode Island pharmacist CE is strictly 15 hours
per calendar year.
Q3: A community pharmacy intends to scale its operations and hire additional support staff.
Under Rhode Island regulations, what is the MAXIMUM allowable ratio of pharmacists to
,pharmacy technicians? A) 1 pharmacist to 2 technicians B) 1 pharmacist to 4 technicians C) 1
pharmacist to 6 technicians D) There is no mandated ratio
● The Answer: D (There is no mandated ratio)
● Distractor Analysis:
○ A is incorrect: This is a highly restrictive legacy ratio utilized in other jurisdictions.
○ B is incorrect: A common national ratio, but not applicable in RI.
○ C is incorrect: Tennessee allows 1:6, whereas RI does not artificially cap the
numbers.
The Mentor's Analysis: Workflow safety is determined by professional judgment, not arbitrary
state math. When designing staffing models, the immediate priority is ensuring adequate
personnel to meet workload demands safely. By utilizing dynamic staffing authorized by the PIC,
you bypass the novice assumption of fixed ratios. Rhode Island relies on PIC professional
judgment, enforcing no strict pharmacist-to-technician ratio.
Q4: A prescriber writes a prescription for Adderall (Schedule II). Under the 2025 legislative
update to R.I. Gen. Laws § 21-28-3.18, what is the MAXIMUM days' supply a prescriber can
authorize on a single prescription for this non-opioid medication? A) 30 days B) 60 days C) 90
days D) 100 days
● The Answer: C (90 days)
● Distractor Analysis:
○ A is incorrect: The 30-day limit was repealed explicitly for non-opioid, non-narcotic
C-IIs.
○ B is incorrect: An arbitrary intermediate limit.
○ D is incorrect: This limit applies to emergency non-controlled continuations, not
C-IIs.
The Mentor's Analysis: Legislation evolves to prevent care interruptions for chronic disease
states. When dispensing stimulants, the immediate priority is distinguishing between opioid C-IIs
and non-narcotic C-IIs. By utilizing the 90-day non-narcotic exemption, you bypass the trap of
illegally restricting ADHD medications. Non-opioid C-IIs allow a 90-day supply per single
dispensation.
Q5: A prescriber issues a prescription for Oxycodone (Schedule II) for a patient suffering from
acute back pain. The patient is opioid-naive. What is the MAXIMUM daily dosage limit permitted
by Rhode Island law for this initial acute prescription? A) 30 Morphine Milligram Equivalents
(MME) B) 50 Morphine Milligram Equivalents (MME) C) 90 Morphine Milligram Equivalents
(MME) D) There is no MME limit, only a 20-dose numerical limit
● The Answer: A (30 Morphine Milligram Equivalents (MME))
● Distractor Analysis:
○ B is incorrect: 50 MME is the chronic PDMP alert threshold, not the initial acute cap.
○ C is incorrect: 90 MME is a federal high-risk threshold.
○ D is incorrect: RI specifically mandates both a 20-dose limit AND a 30 MME daily
limit for initial acute pain.
The Mentor's Analysis: Acute pain management requires the aggressive mitigation of
physiological dependency risks. When verifying initial opioid orders, the immediate priority is
enforcing the strict 30 MME daily ceiling. By utilizing MME conversion tracking, you bypass the
catastrophic error of over-dispensing initial narcotics. Initial acute opioid therapy is
hard-capped at 30 MME/day and 20 total doses.
Q6: A patient requires an emergency refill of Levothyroxine. The prescriber has retired and
cannot be reached. Under R.I. Gen. Laws § 5-19.1-37, what is the MAXIMUM days' supply the
pharmacist may unilaterally dispense to ensure continuation of therapy? A) 3 days (72 hours) B)
, 14 days C) 30 days D) 100 days
● The Answer: D (100 days)
● Distractor Analysis:
○ A is incorrect: 72 hours is the legacy standard for emergency oral C-II
authorizations.
○ B is incorrect: A common commercial insurance override, not the statutory limit.
○ C is incorrect: The 30-day limit is standard in many states, but RI recently expanded
this significantly.
The Mentor's Analysis: Continuity of chronic care supersedes administrative prescribing
barriers. When facing an orphaned patient, the immediate priority is maintaining the patient's
physiological baseline. By utilizing the 100-day continuation protocol, you bypass the novice
error of under-dosing a chronic patient. Rhode Island pharmacists can authorize up to a
100-day supply for essential, non-controlled maintenance medications.
Q7: After unilaterally dispensing a 100-day emergency continuation refill for a non-controlled
medication, within what timeframe MUST the pharmacist formally notify the prescriber of the
dispensing? A) Immediately (within 24 hours) B) Within 7 business days C) Within 14 days D)
Notification is optional if the prescriber is known to be retired
● The Answer: B (Within 7 business days)
● Distractor Analysis:
○ A is incorrect: Immediate notification is impractical and not legally mandated.
○ C is incorrect: 14 days exceeds the strict statutory tracking window.
○ D is incorrect: Notification (or robust internal documentation if no active prescriber
exists) is strictly mandatory.
The Mentor's Analysis: Unilateral clinical action demands immediate retroactive communication.
When acting independently, the immediate priority is syncing the patient's central medical
record. By utilizing statutory notification windows, you bypass fragmented care liability.
Emergency continuation refills require prescriber notification within exactly 7 business
days.
Q8: A pharmacist discovers a dispensing error where a patient ingested the wrong dosage of
Amlodipine. Under 216-RICR-40-15-1, within what MAXIMUM timeframe must this error be
actively analyzed and reported to a patient safety organization? A) 24 hours B) 7 days C) 30
days D) 60 days
● The Answer: C (30 days)
● Distractor Analysis:
○ A is incorrect: 24 hours is required for PDMP data submission, not error reporting.
○ B is incorrect: 7 days is the window for notifying PCPs of emergency refills.
○ D is incorrect: Represents a delayed timeframe outside statutory limits.
The Mentor's Analysis: Systemic quality assurance relies on transparent data sharing. When an
error occurs, the immediate priority is conducting a root-cause analysis and reporting the failure.
By utilizing the 30-day reporting window, you bypass charges of unprofessional conduct for
concealing liability. All dispensing errors must be analyzed and reported to a safety
organization within 30 days.
Q9: Under Rhode Island law, a pharmacist wishes to independently prescribe and dispense a
short-term, FDA-approved hormonal contraceptive. What FIRST action is legally required before
initiating this clinical service? A) Enter into a Collaborative Practice Agreement (CPA) with an
OB/GYN. B) Obtain an advanced practice pharmacist (APh) license. C) Complete a Board of
Pharmacy approved educational training program. D) Perform a physical examination and
obtain baseline vital signs.
RHODE ISLAND PHARMACY
JURISPRUDENCE & GLOBAL STANDARDS
PART 0: THE NAVIGATOR
● Tier 1 (Questions 1–28) - Foundational Syntax & Application: Regulatory timelines,
the Uniform MPJE (UMPJE) transition, controlled substance hard-decks, and baseline
licensing metrics.
● Tier 2 (Questions 29–58) - Complex Application & Simulation: Pharmacist-prescribed
contraceptives, 100-day emergency continuation protocols, PDMP surveillance triggers,
and dynamic staffing regulations.
● Tier 3 (Questions 59–88) - Grandmaster Synthesis: Collaborative Practice Agreements
(CPA), multi-jurisdictional telemedicine friction, test-and-treat execution, and systemic
failure resolution.
PART I: THE PRIMER
Mastering this test bank forges practitioners into elite, liability-proof scholars capable of
dominating the 2026 Rhode Island jurisprudence landscape and translating regulatory theory
into unassailable clinical competence. By fusing hyper-specific state statutes with universal
healthcare governance, this material structurally shields the professional from catastrophic civil,
regulatory, and criminal exposure while optimizing patient outcomes.
The "Critical Axioms" Cheat Sheet:
● The 2026 UMPJE Mandate: The state-specific Rhode Island MPJE was permanently
abolished. As of April 1, 2026, licensure by examination or reciprocity unequivocally
requires passage of the Uniform Multistate Pharmacy Jurisprudence Examination
(UMPJE).
● The 100-Day Safety Net: Under R.I. Gen. Laws § 5-19.1-37, pharmacists possess the
unilateral authority to dispense a 100-day continuation refill for essential, non-controlled
maintenance medications if a prescriber is unreachable or the patient is orphaned.
● The Non-Opioid 90/90 Rule: Schedule II prescriptions expire exactly 90 days from
issuance. Following a radical 2025 legislative update, prescribers may now authorize, and
pharmacists may dispense, up to a 90-day supply of non-opioid, non-narcotic C-IIs (e.g.,
ADHD stimulants) in a single transaction.
● Acute Opioid Hard Deck: Initial acute pain opioid prescriptions are mathematically
restricted. They must not exceed 20 individual doses, nor may they surpass a maximum
threshold of 30 Morphine Milligram Equivalents (MME) per day.
Rhode Island 2026/2027 Core Regulatory Metrics
Metric Statutory Standard Citation
Pharmacist CE Requirement 15 Hours Annually (5 Live, 1
,Metric Statutory Standard Citation
Immunization)
Record Retention 2 Years from Date of
(Prescriptions) Dispensing
Record Retention (Medicaid 10 Years
Logs)
Pharmacist-to-Technician No statutory maximum;
Ratio determined by PIC
Dispensing Error Reporting Within 30 days to a Patient
Safety Organization
PART II: THE ELITE TEST BANK
Tier 1 - Foundational Syntax & Application
Q1: An out-of-state pharmacist applies for reciprocity in Rhode Island in May 2026. Based on
the rules of the Rhode Island Board of Pharmacy, which examination MUST they successfully
complete? A) The Rhode Island specific Multistate Pharmacy Jurisprudence Examination
(MPJE) B) The Multistate Pharmacy Jurisprudence Examination (MPJE) from their home
jurisdiction C) The Uniform Multistate Pharmacy Jurisprudence Examination (UMPJE) D) A
50-question oral jurisprudence board review
● The Answer: C (The Uniform Multistate Pharmacy Jurisprudence Examination (UMPJE))
● Distractor Analysis:
○ A is incorrect: The RI MPJE was permanently retired on April 1, 2026.
○ B is incorrect: Home-state MPJEs do not satisfy the 2026 RI reciprocal requirement.
○ D is incorrect: Oral reviews are legacy mechanics not utilized for standard modern
reciprocity.
The Mentor's Analysis: Regulatory frameworks standardize to remove friction. When facing
jurisdictional entry post-April 2026, the immediate priority is recognizing the UMPJE mandate.
By utilizing the Uniform MPJE compliance pathway, you bypass the novice error of studying
defunct state-specific test structures. Geography yields to uniformity; the UMPJE is the
absolute standard for 2026 RI licensure.
Q2: A licensed Rhode Island pharmacist is auditing their continuing education (CE) credits. To
maintain an active license, how many total hours of CE are REQUIRED per calendar year? A)
10 hours B) 15 hours C) 20 hours D) 30 hours
● The Answer: B (15 hours)
● Distractor Analysis:
○ A is incorrect: This falls below the statutory minimum.
○ C is incorrect: This is a common biennial requirement in other states, but RI tracks
annually.
○ D is incorrect: This represents the requirement for states with biennial 30-hour
cycles.
The Mentor's Analysis: Competency maintenance is a strict annual liability. When renewing
credentials, the immediate priority is fulfilling the baseline 15-hour state mandate. By utilizing
the annual cycle, you bypass audit failures. Rhode Island pharmacist CE is strictly 15 hours
per calendar year.
Q3: A community pharmacy intends to scale its operations and hire additional support staff.
Under Rhode Island regulations, what is the MAXIMUM allowable ratio of pharmacists to
,pharmacy technicians? A) 1 pharmacist to 2 technicians B) 1 pharmacist to 4 technicians C) 1
pharmacist to 6 technicians D) There is no mandated ratio
● The Answer: D (There is no mandated ratio)
● Distractor Analysis:
○ A is incorrect: This is a highly restrictive legacy ratio utilized in other jurisdictions.
○ B is incorrect: A common national ratio, but not applicable in RI.
○ C is incorrect: Tennessee allows 1:6, whereas RI does not artificially cap the
numbers.
The Mentor's Analysis: Workflow safety is determined by professional judgment, not arbitrary
state math. When designing staffing models, the immediate priority is ensuring adequate
personnel to meet workload demands safely. By utilizing dynamic staffing authorized by the PIC,
you bypass the novice assumption of fixed ratios. Rhode Island relies on PIC professional
judgment, enforcing no strict pharmacist-to-technician ratio.
Q4: A prescriber writes a prescription for Adderall (Schedule II). Under the 2025 legislative
update to R.I. Gen. Laws § 21-28-3.18, what is the MAXIMUM days' supply a prescriber can
authorize on a single prescription for this non-opioid medication? A) 30 days B) 60 days C) 90
days D) 100 days
● The Answer: C (90 days)
● Distractor Analysis:
○ A is incorrect: The 30-day limit was repealed explicitly for non-opioid, non-narcotic
C-IIs.
○ B is incorrect: An arbitrary intermediate limit.
○ D is incorrect: This limit applies to emergency non-controlled continuations, not
C-IIs.
The Mentor's Analysis: Legislation evolves to prevent care interruptions for chronic disease
states. When dispensing stimulants, the immediate priority is distinguishing between opioid C-IIs
and non-narcotic C-IIs. By utilizing the 90-day non-narcotic exemption, you bypass the trap of
illegally restricting ADHD medications. Non-opioid C-IIs allow a 90-day supply per single
dispensation.
Q5: A prescriber issues a prescription for Oxycodone (Schedule II) for a patient suffering from
acute back pain. The patient is opioid-naive. What is the MAXIMUM daily dosage limit permitted
by Rhode Island law for this initial acute prescription? A) 30 Morphine Milligram Equivalents
(MME) B) 50 Morphine Milligram Equivalents (MME) C) 90 Morphine Milligram Equivalents
(MME) D) There is no MME limit, only a 20-dose numerical limit
● The Answer: A (30 Morphine Milligram Equivalents (MME))
● Distractor Analysis:
○ B is incorrect: 50 MME is the chronic PDMP alert threshold, not the initial acute cap.
○ C is incorrect: 90 MME is a federal high-risk threshold.
○ D is incorrect: RI specifically mandates both a 20-dose limit AND a 30 MME daily
limit for initial acute pain.
The Mentor's Analysis: Acute pain management requires the aggressive mitigation of
physiological dependency risks. When verifying initial opioid orders, the immediate priority is
enforcing the strict 30 MME daily ceiling. By utilizing MME conversion tracking, you bypass the
catastrophic error of over-dispensing initial narcotics. Initial acute opioid therapy is
hard-capped at 30 MME/day and 20 total doses.
Q6: A patient requires an emergency refill of Levothyroxine. The prescriber has retired and
cannot be reached. Under R.I. Gen. Laws § 5-19.1-37, what is the MAXIMUM days' supply the
pharmacist may unilaterally dispense to ensure continuation of therapy? A) 3 days (72 hours) B)
, 14 days C) 30 days D) 100 days
● The Answer: D (100 days)
● Distractor Analysis:
○ A is incorrect: 72 hours is the legacy standard for emergency oral C-II
authorizations.
○ B is incorrect: A common commercial insurance override, not the statutory limit.
○ C is incorrect: The 30-day limit is standard in many states, but RI recently expanded
this significantly.
The Mentor's Analysis: Continuity of chronic care supersedes administrative prescribing
barriers. When facing an orphaned patient, the immediate priority is maintaining the patient's
physiological baseline. By utilizing the 100-day continuation protocol, you bypass the novice
error of under-dosing a chronic patient. Rhode Island pharmacists can authorize up to a
100-day supply for essential, non-controlled maintenance medications.
Q7: After unilaterally dispensing a 100-day emergency continuation refill for a non-controlled
medication, within what timeframe MUST the pharmacist formally notify the prescriber of the
dispensing? A) Immediately (within 24 hours) B) Within 7 business days C) Within 14 days D)
Notification is optional if the prescriber is known to be retired
● The Answer: B (Within 7 business days)
● Distractor Analysis:
○ A is incorrect: Immediate notification is impractical and not legally mandated.
○ C is incorrect: 14 days exceeds the strict statutory tracking window.
○ D is incorrect: Notification (or robust internal documentation if no active prescriber
exists) is strictly mandatory.
The Mentor's Analysis: Unilateral clinical action demands immediate retroactive communication.
When acting independently, the immediate priority is syncing the patient's central medical
record. By utilizing statutory notification windows, you bypass fragmented care liability.
Emergency continuation refills require prescriber notification within exactly 7 business
days.
Q8: A pharmacist discovers a dispensing error where a patient ingested the wrong dosage of
Amlodipine. Under 216-RICR-40-15-1, within what MAXIMUM timeframe must this error be
actively analyzed and reported to a patient safety organization? A) 24 hours B) 7 days C) 30
days D) 60 days
● The Answer: C (30 days)
● Distractor Analysis:
○ A is incorrect: 24 hours is required for PDMP data submission, not error reporting.
○ B is incorrect: 7 days is the window for notifying PCPs of emergency refills.
○ D is incorrect: Represents a delayed timeframe outside statutory limits.
The Mentor's Analysis: Systemic quality assurance relies on transparent data sharing. When an
error occurs, the immediate priority is conducting a root-cause analysis and reporting the failure.
By utilizing the 30-day reporting window, you bypass charges of unprofessional conduct for
concealing liability. All dispensing errors must be analyzed and reported to a safety
organization within 30 days.
Q9: Under Rhode Island law, a pharmacist wishes to independently prescribe and dispense a
short-term, FDA-approved hormonal contraceptive. What FIRST action is legally required before
initiating this clinical service? A) Enter into a Collaborative Practice Agreement (CPA) with an
OB/GYN. B) Obtain an advanced practice pharmacist (APh) license. C) Complete a Board of
Pharmacy approved educational training program. D) Perform a physical examination and
obtain baseline vital signs.
